Patents over patients? Exploring the variegated financialization of the pharmaceuticals industry through mergers and acquisitions
In recent years the pharmaceutical industry has been accused of prioritising profits from patents at the expense of the wellbeing of patients. Many argue that this transition reflects the full-scale financialization of the industry, whereby an increasing focus on shareholder value and financial perf...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
SAGE Publications
2022
|